Role of Nucleoside Transporters in Nucleoside-Derived Drug Sensitivity
- 10 June 2010
- journal article
- research article
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 29 (4-6) , 335-346
Abstract
Nucleoside-derived drugs are currently used clinically as anticancer drugs. To exert their pharmacological action first they need to enter into the cell across plasma membrane transporters and be metabolized. Thus, efficacy of treatment and acquisition of resistance can rely on a variety of events. In this article, we will focus in the role of nucleoside transporters in the sensitivity to nucleoside-derived drugs used in chemotherapy. Evidence of different transporter protein expression patterns in tumors compared to normal tissues, besides inter-individual variability in the levels of nucleoside transporters in tumors, suggest a major role of nucleoside transporters in the cytotoxicity of nucleoside analogs. In fact, different studies have linked nucleoside transporter function to drug sensitivity and clinical outcome in cancer patients. However, prospective clinical studies analysing nucleoside transporters and metabolic enzymes, as biomarkers of drug metabolism and action are required to better establish the role these proteins might play in cancer chemotherapy.Keywords
This publication has 49 references indexed in Scilit:
- Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Identification of a novel point mutation in ENT1 that confers resistance to Ara‐C in human T cell leukemia CCRF‐CEM cellsFEBS Letters, 2008
- Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemiaLaboratory Investigation, 2008
- Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cellsHaematologica, 2008
- The H Syndrome Is Caused by Mutations in the Nucleoside Transporter hENT3The American Journal of Human Genetics, 2008
- A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter‐3 (hCNT3) protein localized in the endoplasmic reticulumThe FASEB Journal, 2008
- Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic CellsCancer Research, 2008
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007
- Macrophages require different nucleoside transport systems for proliferation and activationThe FASEB Journal, 2001
- Differential Expression of Human Nucleoside Transporters in Normal and Tumor TissueBiochemical and Biophysical Research Communications, 2001